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MembraneSoluble oligomeric aggregates of α-synuclein have been implicated to play a central role in the pathogenesis
of Parkinson's disease. Disruption and permeabilization of lipid bilayers by α-synuclein oligomers is
postulated as a toxic mechanism, but the molecular details controlling the oligomer–membrane interaction
are still unknown. Here we show that membrane disruption strongly depends on the accessibility of the
hydrophobic membrane core and that charge interactions play an important but complex role. We
systematically studied the inﬂuence of the physical membrane properties and solution conditions on lipid
bilayer disruption by oligomers using a dye release assay. Varying the lipid headgroup composition revealed
that membrane disruption only occurs for negatively charged bilayers. Furthermore, the electrostatic
repulsion between the negatively charged α-synuclein and the negative surface charge of the bilayer inhibits
vesicle disruption at low ionic strength. The disruption of negatively charged vesicles further depends on
lipid packing parameters. Bilayer composition changes that result in an increased lipid headgroup spacing
make vesicles more prone to disruption, suggesting that the accessibility of the bilayer hydrocarbon core
modulates oligomer–membrane interaction. These data shed important new insights into the driving forces
governing the highly debated process of oligomer–membrane interactions.© 2009 Elsevier B.V. All rights reserved.1. IntroductionParkinson's disease (PD) is a common neurodegenerative dis-
order marked by increased cell death within the substantia nigra
[1]. The molecular mechanisms causing this neuronal cell loss re-
main a mystery, hampering the development of an effective treat-
ment for the disease. The pathological hallmark of PD is the
occurrence of intracellular deposits of aggregated protein within
Lewy bodies and Lewy neurites [2]. These inclusion bodies contain a
large amount of the protein α-synuclein (αS), which suggests that
this protein might be involved in the pathogenesis of the disease [3].
Three point mutations of αS causing rare early-onset forms of the
disease have been identiﬁed [4–6]. Additionally, αS gene duplication
[7] and triplication [8] have been linked to PD and diffuse Lewy body
disease.
αS is a 140 amino acid protein which is expressed throughout the
whole human central nervous system [9]. Although its exact role
within the cell is unknown it has been suggested that membrane
interaction is important for its function [10]. In aqueous solution αS
adopts a random coil conformation [11], but in the presence of nega-
tively charged phospholipid vesicles, the N-terminal residues ∼1–100
have been shown to facilitate lipid binding by adopting an α-helicalramaniam).
ll rights reserved.conformation [12–15]. In vitro, αS can aggregate into amyloid-like
ﬁbrils rich in β-sheet structure that resemble those found in neuronal
protein deposits in vivo [16].
Although Lewy bodies have historically been associated with
Parkinsonism, their role in the onset and progression of the disease is
not understood [17–19]. The amount of ﬁbrillar aggregates within the
brain does not necessarily correlate with disease progression [20].
Furthermore, familial disease mutants exhibit larger oligomerization
rates, but not enhanced ﬁbril formation [21]. As a result, early oligo-
meric intermediates in the aggregation process of αS have been
hypothesized to be the toxic species. A proposed mechanism of
toxicity is lipid membrane disruption [22,23]. An increased perme-
ability of the cellular membrane could lead to neurodegeneration via
an altered calcium homeostasis [24]. In vitro it has been shown that
αS spherical oligomers can disrupt phospholipid vesicles [25]. The
proposed disruption mechanism is the formation of pore-like
structures within the lipid bilayer. This hypothesis has been supported
by single channel recording [26,27], a selectivity for the marker size in
an efﬂux assay [28] and the observation of donut shaped complexes by
atomic force microcopy and electron microscopy [29,30].
The pore-like mechanism is still highly controversial and other
mechanisms such as bilayer thinning have been proposed [31]. To
correctly identify the mechanism through which membrane permea-
bilization is facilitated, it is crucial to understand the interaction
between the oligomers and lipids. However, very little is known about
what factors determine this interaction.
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disruptive effect of αS oligomers using a dye release assay on lipid
vesicles. By systematically altering the vesicle lipid composition and
solution conditions we mapped the fundamental driving forces
governing the oligomer–lipid interaction. We show that membrane
permeabilization is mainly determined by the presence of negatively
charged lipids in the bilayer. At low ionic strengths, vesicle disruption
was inhibited, thereby suggesting a complex role for electrostatic
interactions. Furthermore, both the headgroup speciﬁcity of the
interaction and the dependence on the bilayer packing parameters
imply that disruption occurs through interaction with the bilayer
core.
2. Materials and methods
2.1. Expression and puriﬁcation of recombinant αS
Expression of the human wild-type αS and the disease related
mutant proteins A30P, E46K and A53T were performed as described
[32].
2.2. Preparation of αS oligomeric and ﬁbrillar species
To prepare the αS oligomeric species, 250 μM stock solutions of
αS monomers in 10 mM Hepes pH 7.4, were dried in a vacuum
evaporator and dissolved using MilliQ water at a protein concen-
tration of 1 mM. The protein solution was incubated in an Eppen-
dorf thermo mixer for 18 h at room temperature at 1250 rpm.
After ﬁltration through a 0.2 μm spin-X centrifugal ﬁlter (Corning)
to remove possible large aggregates, the oligomeric species were
separated from the monomeric protein by size-exclusion chroma-
tography on a Superdex 200 (GE) gel ﬁltration column using 10 mM
Hepes pH 7.4, 150 mM NaCl as eluant. Fractions containing the αS
oligomers, judged from UV absorption spectra, were pooled and
concentrated using a Vivaspin (Sartorius) concentrator with a
10 kDa molecular weight cutoff. The protein concentration was
estimated by measuring the absorption at 275 nm. A correction
for scattering was applied as [33], which was generally around
10–15% in magnitude. Mature αS ﬁbrils were prepared by incubat-
ing the stock protein solution in a thermo mixer for 10 days at 37 °C
at 1250 rpm. The aggregated protein was pelleted by centrifugation
for 40 min at 21,000×g. The pellet was washed and resuspended
twice in 10 mM Hepes, pH 7.4, 150 mM NaCl. To estimate the
protein concentration in the ﬁbril containing solution, the aggre-
gates were dissolved in 5M guanidine hydrochloride, and the
protein concentration was calculated from the absorption measured
at 275 nm.
2.3. Immunoblotting
2 μl of monomeric and oligomeric αS (20 μM both) were absorbed
to a nitrocellulose membrane. After blocking for 2 h with 10% non fat
dry milk, 10 mM Tris–HCl pH7.4, 150 mM NaCl, 0.05% Tween20, dot
blots were incubated for 2 h with either the A11 anti oligomeric
antibody (Chemicon) or an anti αS antibody (Sigma) in 5% non fat
dry milk, 10 mM Tris–HCl pH7.4, 150 mM NaCl, 0.05% Tween20.
Subsequently blots were incubated for 1 h with a goat-anti-mouse
secondary antibody coupled to horse radish peroxide (Sigma).
Immunoreactivity was detected on a Nikon imaging station from the
luminescence after adding SuperSignal pico substrate (Pierce).
2.4. Native gradient PAGE
Polyacrylamide gels were cast with a linear gradient from 3 to 17%.
Gels were run under non-denaturing conditions. Ferritin (440 kDa)
was loaded as a molecular weight marker.2.5. Atomic force microscopy
Atomic force microscopy (AFM) images were obtained using
tapping mode AFM in air, on custom-built equipment [34]. Samples
were prepared by placing a 5 μl drop of protein solution on a piece
of freshly cleaved mica. The protein was allowed to adsorb to the
surface by incubating for 5 min in a humid environment. After
incubation, excess liquid was removed and the sample was washed
twice with 20 μl MilliQ water which was immediately blotted off.
Finally, the sample was dried under a gentle stream of nitrogen
gas.
2.6. Electron microscopy
A 5 μl aliquot of protein solution was placed on a carbon coated
copper grid and was allowed to adsorb to the grid during a 5 minute
incubation period under a humid atmosphere to prevent complete
drying. Drops of MilliQ water and 2% ammonium molybdate were
placed on a piece of paraﬁlm. The grid was washed by touching the
drop of MilliQ water which was immediately blotted off. The grid was
then stained by touching a drop of staining solutionwhichwas blotted
off after 30 s. The samples were imaged in a Philips CM300ST-FEG
transmission electron microscope.
2.7. Circular dichroism
Circular dichroism (CD) spectra were recorded using a Jasco 715
spectropolarimeter using a 0.05 cm path length quartz cuvette.
Monomeric and oligomeric species of αS at 10 μM concentrationwere
prepared in 5 mM Tris–Borate pH 7.5 buffer. After recording the CD
spectra, POPG LUVs obtained by extrusion through an 80 nm ﬁlter
were added to a ﬁnal protein lipid ratio of 1:100 and the spectrum in
the presence of lipids was recorded.
2.8. Liposome preparation
1-Palmitoyl, 2-oleoyl phosphatidylcholine (POPC), 1-palmitoyl, 2-
oleoyl phosphatidylglycerol (POPG),1,2-dioleoyl phosphatidylglycerol
(DOPG),1-oleoyl phosphatidylglycerol (lyso PG), 1,2-dilinoleoyl phos-
phatidylglycerol (18:2 PG), 1-palmitoyl, 2-oleoyl phosphatidylserine
(POPS), 1,2-dioleoyl phosphatidylserine (DOPS), 1,2-dioleoyl phos-
phatidic acid (DOPA), 1,2-dioleoyl phosphatidylethanolamine (DOPE),
soy L-α-phosphatidylinositol (PI), bovine heart cardiolipin (CL) and
cholesterol (chol) were all obtained from Avanti Polar lipids and
used without further puriﬁcation. The various lipid compositions
were prepared by mixing the chloroform dissolved lipids to speciﬁc
ratios. Lipid acyl chain compositions were chosen to minimize the
chance of phase separation in the mixtures. To prepare large unila-
mellar vesicles (LUVs), a thin lipid ﬁlm was formed by drying around
0.5 mg of lipid in a glass tube using a gentle stream of N2. Trace
amounts of solvent were removed by drying under vacuum for 4 h.
The lipid ﬁlm was then hydrated by adding a solution of 50 mM
calcein (Sigma), 10 mM Hepes, pH 7.4 Appropriate amounts of NaCl
were added to maintain an osmotic strength equal to 10 mM Hepes
pH 7.4, 150 mM NaCl. Hydration was continued for 1 h, with vortexi-
ng approximately every 15 min. The sample was subsequently
subjected to 5 freeze–thaw cycles by dipping into liquid nitrogen and
thawing above the lipid phase transition temperature. The resulting
solution was extruded 11 times through a polycarbonate membrane
ﬁlterwith a deﬁned pore size. This procedurewas repeated oncewith a
new ﬁlter. Unencapsulated dye was separated from the vesicles by gel
ﬁltration through a PD10 column packed with Sephadex G-100 (GE).
The vesicle size distribution was measured using dynamic light
scattering on a Malvern Zetasizer 4000 instrument. The total phos-
pholipid concentration was determined according to the protocol of
Chen et al. [35].
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For the efﬂux assay the stock vesicle solution was ﬁrst diluted to
twice the ﬁnal phospholipid concentration and then thoroughly
mixed with an equal volume of protein solution. After 30 minutes of
incubation the maximum intensity of the ﬂuorescence emission
spectrum for excitation at 497 nm was recorded on a Varian Cary
Eclipse ﬂuorimeter. After subtraction of the background, leakage was
expressed as a percentage of the maximum possible effect due to
vesicle disruption induced by the addition of 0.5% (weight/volume)
Triton X-100. All experiments were performed in triplicate. The
standard deviations from these triplicates are indicated as the error
bars in all ﬁgures. Experiments aiming to elucidate the inﬂuence
of a certain single parameter were performed on the same pre-Fig. 1. Characterization of puriﬁed oligomeric wild typeαS. (A) Size exclusion chromatogram
monomeric (m) peak. Smaller aggregates, possibly dimers (d), elute just before the monome
antibody showed both reactivity to monomeric (m) and oligomeric (o)αS. The anti oligomer
polyacrylamide gradient form 3 to 17%. Puriﬁed αS oligomers did not contain any monome
monomeric (m) peak of the chromatogram shown in A. Ferritin (f) was included as a mole
weight band above the ferritin band. (D) Tapping mode AFM in air of αS oligomers adsorbe
oligomers. (F) CD spectrum of monomeric and oligomeric αS in the presence and absence of
oligomeric αS. The leakage kinetics contains an initial fast phase, after which leakage graduparation of oligomers, to negate possible batch to batch differences
in oligomer preparation and potential errors in the concentration
determination.
2.10. Ionic strength assay
For the ionic strength experiment, solutions of 10 mM Hepes pH
7.4 containing 0 mM, 5 mM or 50 mM NaCl were prepared. For these
solutions vesicles were hydrated in 50 mM calcein, 10 mM Hepes pH
7.4. The NaCl buffer solutions were adjusted with sucrose to equal
osmolarity as the vesicle hydration solution. Vesicles for the NaCl
concentration of 150 mM were prepared as described earlier. αS
oligomers were prepared in the appropriate buffer by buffer exchange
from a stock solution, using a Zeba Spin desalting column (Pierce).of the puriﬁcation of αS oligomers. The oligomeric peak (o) is easily separated from the
ric peak. (B) Immunoblotting with antiαS and the A11 anti oligomeric antibody. Anti αS
icαS antibody only showed reactivity to oligomericαS. (C) Native gradient PAGE with a
ric protein. Lanes were loaded with fractions from the oligomeric (o), dimeric (d) and
cular weight marker (440 kDa). Oligomeric αS is observed as a broad high molecular
d to a mica surface (1.5 μm scan size). (E) TEM image of ammonium molybdate stained
POPG LUVs. (G) Kinetics of calcein efﬂux from 20 μMPOPG LUVs as induced by 0.015 μM
ally continues.
Fig. 3. Calcein efﬂux from 20 μM POPG LUVs induced by 1 μM oligomeric αS (grey bars)
fromwild type (WT), A30P, E46K and A53TαS. Oligomers from all mutants were able to
disrupt the POPG LUVs.
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3.1. Oligomer characterization
One of the challenges in elucidating the interaction between αS
oligomers and phospholipids is reliable production of the oligomeric
species. Little is known about the actual structure of the oligomeric
intermediate and its role in the aggregation process. Puriﬁcation of the
oligomers generally does not result in a single homogenous popula-
tion of an oligomeric state but rather gives a broad distribution of
protein aggregates of different sizes [29]. We therefore carefully
characterized the oligomeric species produced.
Preparation of oligomeric αS resulted in low yields (2–4%), as can
be seen in the chromatogram in Fig.1A. Increasing the incubation time
did not improve the yield, possibly due to the consumption of these
oligomers by ﬁbrillar αS. The puriﬁed oligomers bound the A11
antibody, which is speciﬁc for oligomeric intermediates in the
aggregation pathway of many amyloidogenic proteins [36] (Fig. 1B).
NomonomericαS could be detected in the puriﬁed oligomer solutions
using native PAGE (Fig. 1C).
In AFM images the puriﬁed oligomers appeared as spherical
aggregates with heights in the range of 2–8 nm (Fig. 1D). Electron
microscopy images of negatively stained oligomers showed spherical
and donut shaped particles of around 6–11 nm (Fig. 1E).
The secondary structure of the oligomeric species was charac-
terized using CD spectroscopy. The oligomeric intermediate has
been reported to possess a β-sheet structure [25]. Monomeric αS
showed a CD spectrum characteristic of an intrinsically disordered
protein (Fig. 1F). Addition of an excess of negatively charged POPG
lipid vesicles induced a conformational change to a predominantly
α-helical structure as has been reported before [13]. The puriﬁed
oligomeric species contained β-sheet structure, and no major con-
ormational changes were observed upon the addition of anionic
lipids.
3.2. Membrane permeabilization
Membrane disruption by αS was characterized using a dye efﬂux
assay. LUVs were ﬁlled with 50 mM calcein, a concentration at which
calcein ﬂuorescence self-quenches. Upon leakage from the vesicle,
quenching of the dye is relieved and a ﬂuorescence signal is observed.
The intensity after 30 min of incubationwas measured. The kinetics of
dye leakage induced by oligomeric αS are relatively fast, making this
essentially an endpoint measurement (Fig. 1G). The extent of dye
leakage from POPG LUVs was clearly dependent on the proteinFig. 2. Dependence of the content leakage from POPG LUVs on the concentration of αS
monomers, oligomers and ﬁbrils at a phospholipid concentration of 20 μM. Leakage is
expressed as a percentage of the maximum possible effect induced by the addition of
Triton X-100. The protein concentration for the oligomeric and ﬁbrillar species is given
as the equivalent monomer concentration.concentration for all aggregation states (Fig. 2). Oligomeric αS was
themost effective in disrupting the LUVs and induced a 50% leakage of
the LUVs at a concentration of ∼0.13 μM. Both the monomeric and
ﬁbrillar formof the proteinwere also able to disrupt the LUVs, although
at signiﬁcantly higher protein concentrations. These induced 50%
vesicle leakage at∼21 μMand∼7.0 μMrespectively. The disease related
mutants A30P, E46K and A53T showed similar disruptive properties
(Fig. 3).
3.3. Lipid headgroup speciﬁcity
It is not knownwhich properties of the lipid bilayer determine the
interaction with the oligomeric intermediates. Membrane permeabi-
lization by αS oligomers has been reported to depend on lipid
headgroup composition [28,37], but the data are contradictory. To
assess the headgroup speciﬁcity for membrane disruption, we
prepared LUVs composed of phospholipids with different head-
groups. The results from these experiments clearly show that only
vesicles composed of negatively charged phospholipids show dye
efﬂux upon addition of 1 μM of oligomeric αS (Fig. 4). POPG, PI and
DOPS all showed calcein efﬂux upon addition of the oligomeric
species. LUVs from the zwitterionic POPC were not disrupted by αS.
This suggests that charge interactions play an important role in
oligomer–lipid interaction. Mixing zwitterionic lipids, such as POPC
and DOPE, with anionic lipids in a 1:1 molar ratio, inhibited the
vesicle disruption for POPG, DOPS and PI containing vesicles. Vesicle
preparations from the anionic lipids DOPA and CL were rather
unstable. Therefore, to probe the interaction of oligomeric αS with
these lipids, vesicles were prepared from 1:1 mixtures of anionic CL
and DOPA with zwitterionic POPC. These vesicles showed consider-
able dye release. When the ratio of zwitterionic lipids to anionic lipid
was changed to 3:1, dye efﬂux was fully inhibited in both the POPC:
DOPA and the POPC:CL LUVs.
Monomeric and ﬁbrillar αS were also added to the LUVs at a ten
times higher concentration. These induced some dye efﬂux from POPG
LUVs and from PI LUVs. The amount of efﬂux was still smaller than the
efﬂux induced by 1 μM oligomeric αS.
To further investigate the role of charge interactions in αS induced
membrane disruption, a dye release experiment at different ionic
strengths was performed (Fig. 5). This revealed very clearly that at
low ionic strength (0 and 5 mM added NaCl) vesicle disruption was
strongly inhibited. At higher salt concentrations of 50mM and 150mM
NaCl a clear concentration dependent calcein efﬂux was observed.
3.4. Lipid packing parameters
The increased sensitivity of DOPA and CL to oligomericαSmight be
related to their small headgroup size. Thus the accessibility of the
Fig. 4. Calcein efﬂux from LUVs of different lipid compositions induced by 10 μM monomeric, 1 μM oligomeric and 10 μM ﬁbrillar at a phospholipid concentration of 20 μM. Lipid
mixtures were prepared in a 1:1 molar ratio, unless noted otherwise.
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interaction of oligomeric αS. Moreover, small unilamellar vesicles
(∼30 nm) have been shown to be more vulnerable to disruption by
the oligomeric species [25]. Curvature stress within the bilayer, which
can lead to packing defects, is a possible explanation for such an effect.
Although the exact nature of such defects is not clear, theymight allow
proteins to more easily interact with the hydrophobic core of the
membrane [38]. These data indicate that lipid packing parameters
could critically determine oligomer–lipid interactions. We therefore
investigated the effect of lipid packing properties on the disruption of
vesicles by αS oligomers.
First, lipid packing was modulated by altering the spontaneous
curvature of the phospholipids in the bilayer which is known to have a
large effect on lipid protein interaction [38,39]. The spontaneous
curvature of a lipidmonolayer is a result of the shape of the lipids [40].
Lipids with a small headgroup have a negative radius of curvature,
whereas lipids with a single acyl chain have a positive radius of
curvature [38]. DOPA, CL and POPG in high salt concentrations are
expected to have negative spontaneous curvature [41]. However in
LUVs the lipids are packed in an almost planar bilayer. Thus in vesicles
composed of these lipids the hydrophobic lipid bilayer core might be
more exposed to the oligomers. The spontaneous curvature can be
modulated towards a more positive value without changing the
headgroup compositions by adding lipids with a single acyl chain [41]
thereby optimizing lipid packing of the LUVs and relieving curvature
stress. Lyso PG was added at different ratios to POPG fromwhich LUVs
were subsequently obtained by extrusion. Membrane permeability
induced by the addition of αS oligomers was measured at different
protein concentrations. The results are shown in Fig. 6A. Pure POPG
LUVs showed a 50% leakage at a αS concentration of 0.25 μM.
Optimizing the lipid bilayer packing by the addition of increasing
amounts of lyso PG stabilized the vesicles against permeabilization by
αS, with 50% leakage at 0.42 μM αS for 10% lyso PG and at 0.79 μM αSFig. 5. The effect of the ionic strength of the solution on the disruption of POPG LUVs
measured by calcein efﬂux at a phospholipid concentration of 20 μM.αS oligomerswere
added at different concentrations to the vesicle solution in the presence of 0 mM, 5mM,
50 mM and 150 mM NaCl.for 20% lyso PG containing vesicles. This result indicates that lipid
packing of the LUVs, and thus the accessibility of the membrane core,
is an important factor in oligomer–lipid interaction.
Lipid packing is also affected by changing the amount of
unsaturated bonds in the lipid hydrocarbon chains. Upon increasing
unsaturation, chain disorder increases and the average headgroup
spacing becomes larger, resulting in a thinner bilayer [42]. To probe
the effects of lipid chain packing, LUVs of lipids with phosphatidyl
glycerol headgroups containing different acyl chain conﬁgurations
were produced. Fully saturated lipids were not probed because of the
high gel to ﬂuid phase transition temperature of these lipids.
Furthermore, POPG LUVs containing 25% cholesterol were prepared.Fig. 6. (A) The effect of headgroup spacing on oligomer-induced vesicle leakage. LUVs
were prepared from POPG with different amounts of lyso-PG. Total lipid concentration
was 25 μM with vesicles containing 0%, 10% and 20% lyso PG. (B) Inﬂuence of lipid
packing parameters on oligomer induced vesicle disruption. Plot of the concentration
dependent oligomer-induced dye release from 20 μM PG LUVs with different acyl
chains: POPG, DOPG, 18:2 PG and POPG:cholesterol 3:1.
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enhances the cohesive interactions within the bilayer which results in
a more densely packed bilayer [42]. The effect of αS on the perme-
ability of these different LUVs was measured at different oligomer
concentrations as shown in Fig. 6B. The results reveal that upon
increasing saturation the vesicles are more stable against αS induced
permeabilization. The amount of dye release from the different lipid
compositions was most efﬁcient in 18:2 PG and decreased upon
increasing chain saturation. The addition of 25% cholesterol to POPG
LUVs further stabilized these vesicles. The oligomer concentrations at
which 50% leakage is induced are as follows: 18:2 PG 0.08 μM, DOPG
0.1 μM, POPG 0.15 μM and POPG:Chol 0.2 μM. These data conﬁrm that
an increase in lipid headgroup spacing facilitates the interaction of the
oligomer with the membrane.
Interestingly monomeric αS has been reported to optimize lipid
packing in small vesicle [43]. Correspondingly, adding a small amount
of monomeric αS to LUVs can prevent the membrane permeabiliza-
tion by oligomeric αS (Supporting information, Fig. S1).
4. Discussion
Membrane disruption by αS oligomers is often considered as a
likely mechanism of cytotoxicity in PD. However, due to the lack of
understanding of the fundamental molecular mechanisms involved, it
is difﬁcult to estimate the biological relevance of this process. In this
workwe sought to elucidate the fundamental driving forces governing
oligomer–lipid interactions by studying how physicochemical bilayer
properties inﬂuence αS oligomer-induced vesicle disruption.
Oligomeric αS is generally prepared by allowing the protein to
aggregate for a certain time and isolating the oligomeric intermediates
before they are converted into ﬁbrillar αS. A multitude of conditions
have been applied in different laboratories to induce αS oligomeriza-
tion. These different conditions might result in structurally and func-
tionally different oligomers and can therefore be difﬁcult to compare.
The structure of αS is experimentally not easily accessible and no
detailed structural information is available. Generally, αS oligomers
are reported as spherical protein aggregates with sizes between 2 and
20 nm. Annular and tubular morphologies are sometimes reported.
We have used an increased protein concentration to induce aggre-
gation. Oligomeric αS prepared using this protocol exhibit morpho-
logical and structural characteristics similar to those reported by
others [29,30].
4.1. Vesicle permeabilization
Our experiments clearly show that αS oligomers can permeabilize
POPG LUVs in a concentration dependent fashion. Using similar
conditions, Volles et al. [28] found leakage at around 30 times lower
protein to lipid ratios; this is possibly the result of the size of the
markers used in the different assays used: calcein efﬂux versus
calcium inﬂux. Furthermore, the divalent calcium cation can have a
profound effect on negatively charged vesicles in general and on αS–
lipid interaction speciﬁcally [44,45].
At very high protein concentrations monomeric and ﬁbrillar forms
of αS were also able to induce calcein leakage from POPG LUVs.
MonomericαS is thought to disrupt LUVs in a detergent like way. How
ﬁbrillar αS could cause membrane damage is not known; apparently
ﬁbrillar αS is able to bind to a lipid bilayer. We however cannot
exclude the possibility that the monomeric protein forms aggregates
on the lipid membranes or that the ﬁbrils dissociate into oligomers.
Oligomerization of monomeric αS on the membrane surface has been
suggested by MD simulation [46] and aggregation experiments [47],
while single channel activity has been observed upon addition of the
monomeric protein [48].
αS oligomers from the disease related mutants A30P, E46K and
A53T showed very similar leakage characteristics. Although no majorquantitative difference in induced leakage was observed between the
different mutants, oligomers derived from A30P αS appeared to
induce the least vesicle disruption. Interestingly, monomeric A30P αS
is also reported to bind lipids with a lower afﬁnity than wild type αS
and the E46K and A53T mutants [49,50].
4.2. Driving forces
Our results indicate that only negatively charged vesicles are
affected by oligomeric αS. Therefore charge interactions appear to
determine oligomer mediated membrane disruption. Monomeric αS,
although highly negatively charged, speciﬁcally binds to negatively
charged membranes [13,14]. This binding is explained by the fact that
at neutral pH the N-terminal lipid binding region contains many
positively charged residues. Furthermore, most of the negative charge
is concentrated in the C-terminus of the protein, which remains
unstructured in solution upon protein–lipid binding [51]. Although
the structure of oligomeric αS in its free and lipid bound state is not
known, a clear charge separation as in the monomeric protein seems
unlikely to be energetically favorable. However binding of oligomeric
αS to negatively charged vesicles has been reported [28] and we have
observed a binding speciﬁcity of oligomeric αS for negatively charged
lipids [52]. Therefore charge interactions appear to play a crucial role
in oligomer–lipid binding.
The role of charge interactions in oligomer membrane disruption
appears to be more complex. Calcein efﬂux experiments at different
ionic strengths showed that leakage is inhibited at low salt
concentrations. For binding mediated by charge interaction we
would have expected to observe stronger binding and thus leakage
at lower protein concentrations. Possibly, reduced screening of
electrostatic interactions at low ionic strength between the negatively
charged oligomers and the bilayer surface causes an electrostatic
repulsion inhibiting binding. Positively charged or hydrophobic
patches on the surface of the oligomer might support the oligomer
binding. However, there are many contributing factors making it
difﬁcult to pinpoint the exact binding mechanism. For instance, the
structure of the αS oligomers might change as an effect of ionic
strength. Finally, lipid packing parameters are also inﬂuenced by the
ionic strength, further contributing to the complexity of the system.
In addition to bilayer charge, lipid packing parameters also
inﬂuence the oligomer-induced vesicle disruption. We observed that
more densely packed bilayers were more resistant to disruption. This
suggests that hydrophobic interactions contribute to oligomer–lipid
binding. The membrane interior of loosely packed bilayers is much
more accessible. Interaction with the membrane hydrocarbon core
might facilitate binding and disruption. Interestingly, addition of
monomeric αS protects the LUVs from disruption by oligomeric αS.
MonomericαS is known to bind to defects in the lipid bilayer and thus
can have a stabilizing effect on small vesicles [43].
4.3. Mechanism of disruption
One of the key questions in oligomer–lipid interactions revolves
around the mechanism by which bilayer disruption occurs. The
dependence of membrane disruption on the bilayer physical proper-
ties can give important information on the most likely mechanism of
membrane disruption [53]. Besides a pore-like mechanism [26,28],
membrane thinning has been suggested as a possible mode of action
[31,54]. Adsorption of the oligomeric intermediates to the surface of
the bilayer could cause an increase in the average headgroup spacing
and thus have a thinning effect. Bilayer thinning increases the
membrane permeability by decreasing the thickness of the hydro-
phobic barrier. Lipid bilayers that are more easily compressed are
expected to show greater membrane permeability. Addition of
cholesterol to the bilayer which reduces the compressibility of the
bilayer did show a slight inhibitory effect. Our results suggest that a
1277B.D. van Rooijen et al. / Biochimica et Biophysica Acta 1788 (2009) 1271–1278thinner membrane with increased headgroup spacing facilitates the
leakage process. However, thinning of the bilayer may be the cause
of oligomer–lipid interaction and not necessarily the effect. Pore
formation through oligomer insertion into the bilayer core still offers a
possible explanation for all the observed effects.
4.4. Biological signiﬁcance
From the observed lipid speciﬁcity one could predict likely cellular
targets for αS oligomer membrane disruption. The plasma membrane
is rich in sterols, sphingolipids and phosphatidylcholines [55]. Our
data show that POPC and cholesterol both inhibit leakage therefore
the plasma membrane is not a likely target for oligomeric αS.
Although αS in its monomeric and aggregated form have been
observed in the extracellular space and can be possible secreted or
released from dying cells [56], the majority of the protein is
intracytoplasmic. Therefore the membranes of organelles are also a
possible target of αS oligomers. In this light the observed leakage
speciﬁcity for the mitochondrial lipid cardiolipin suggests that mito-
chondria could be vulnerable to αS oligomers. Mitochondrial dys-
function has long been suggested to play a potential role in the
pathogenesis of PD [19]. αS has been observed to localize to mito-
chondria [57], which is increased upon αS overexpression [58] and
intracellular acidiﬁcation [59]. Mitochondrial localization of αS is
possibly mediated by cardiolipin since monomeric αS has been
reported to bind cardiolipin with high afﬁnity [60] in vitro. Possibly,
αS oligomers directly induce mitochondrial membrane damage.
Additionally interactions with mitochondrial proteins, such as
mitochondrial complex I could also be a source of cell damage [61–
63]. However, it should be pointed out that membrane disruptionwas
only observed inmembraneswhich have high anionic lipid content. At
physiologically more relevant concentrations, such as POPC:Cl 3:1
membrane disruption was inhibited. How these results translate to
the effect of αS oligomers in vivo is unclear, since real biological
membranes are much more heterogeneous and contain distinct
domains that may mediate oligomer–membrane interactions.
Elucidating the toxic species in the aggregation of αS and pin-
pointing the exact mechanisms involved still remains one of the
biggest challenges in the ﬁeld. The process of αS aggregation is highly
dynamic and a multitude of aggregation intermediates possibly
possesses different lipid binding properties. Such a complicated and
heterogeneous system is difﬁcult to access experimentally in a cellular
context. Therefore biophysical and biochemical data as presented here
offer important insights into how oligomeric αS could interact with
cellular components.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamem.2009.03.010.
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